Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMISO: Optimising misoprostol protocol for labour induction
2026-525770-19-00Phase 4Authorised
- Sponsor
- Fakultní nemocnice Brno
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of misoprostol (2 arms), sponsored by Fakultní nemocnice Brno. Primary endpoint: Total misoprostol dose. Planned start May 2026; status: authorised.
02
Drugs
misoprostol
Beyond the preview
Go deeper on 2026-525770-19-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-525770-19-00.